Taiwan to buy 10 million doses of locally produced COVID-19 vaccines
ROC Central News Agency
05/30/2021 09:32 PM
Taipei, May 30 (CNA) The Central Epidemic Command Center (CECC) said Sunday that the Taiwan government has signed contracts with two domestic companies to purchase a total of 10 million COVID-19 vaccine doses.
The Centers for Disease Control has inked contracts with Medigen Vaccine Biologics Corp. and United Biomedical to buy 5 million vaccine doses from each of them, CECC spokesperson Chuang Jen-hsiang (èŽŠäººç¥¥) told reporters.
The contracts are flexible, however, allowing the government to purchase up to 10 million doses from each of the two companies, if it wishes, he said.
The vaccines developed by Medigen and United Biomedical are still in second-stage clinical trials, and the companies have said they plan to apply in June for emergency use authorization.
Both vaccines require two doses.
Taiwan has signed contracts to purchase nearly 20 million vaccines from overseas, including 5.05 million doses of Moderna, 10 million AstraZeneca, and 4.76 million doses of unspecified brands through the COVAX program.
It has so far received 726,600 doses of AstraZeneca and 150,000 doses of Moderna.
A total of 378,277 people in Taiwan have received their first COVID-19 shots, according to the latest CECC data.
(By Chen Chieh-ling, Chiang Hui-chun and Chiang Yi-ching)
|Join the GlobalSecurity.org mailing list|